NFKB1 and melanoma: In mouse melanoma B16F10 cells, casticin treatment also showed that it impaired cell migration and invasion, decreased the expressions of MMP-9, MMP-2, and MMP-1, and inhibited the phosphatidylinositol 3-kinase (PI3K)/Akt and NF-κB signaling pathways [17].